![](/img/cover-not-exists.png)
Outcome of patients with low-risk and intermediate-1-risk myelodysplastic syndrome after hypomethylating agent failure: A report on behalf of the MDS Clinical Research Consortium
Jabbour, Elias J., Garcia-Manero, Guillermo, Strati, Paolo, Mishra, Asmita, Al Ali, Najla H., Padron, Eric, Lancet, Jeffrey, Kadia, Tapan, Daver, Naval, O'Brien, Susan, Steensma, David P., Sekeres, MiVolume:
121
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.29145
Date:
March, 2015
File:
PDF, 208 KB
english, 2015